跳至主要内容
临床试验/NCT05679297
NCT05679297已完成不适用

Structural and Functional Grey and White Matter Changes in Patients With Pain Disorders

University Hospital, Basel, Switzerland1 个研究点 分布在 1 个国家目标入组 82 人开始时间: 2015年5月4日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
82
试验地点
1
主要终点
The exact lesion location in the thalamus in patients with thalamic pain compared to patients with thalamic stroke without pain

研究概览

简要总结

The goal of this observational study is to examine the association between exact lesion location and presence of thalamic CPSP (Central post-stroke pain) in a larger number of patients after thalamic stroke.

详细描述

The researchers will explore how the brain areas and mechanisms of brain plasticity are involved in the generation of thalamic CPSP, compared to other pain disorders, using structural and functional magnetic resonance imaging (MRI) at 3 Tesla. The functional magnetic resonance imaging (fMRI) will be also used to assess the cerebral processing of heat/cold stimuli in patients with thalamic pain compared to thalamic stroke patients without pain, to patients with migraine (other central pain disorder) and to normal controls. In addition the researchers want to assess the somatosensory profile of thalamic pain patients and compare it with thalamic stroke patients without pain, patients with migraine (pain control) and normal controls.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with thalamic central post-stroke pain (CPSP) :
  • Patients fulfilling all of the following inclusion criteria are eligible for the study:
  • Informed Consent as documented by signature (Appendix Informed Consent Form)
  • History of thalamic stroke (infarction or bleed)
  • Diagnosis of definite central-post stroke pain (according to the criteria proposed by Klit et al, 2009)
  • No other chronic pain condition
  • Age: ≥18 years old
  • Patients with thalamic stroke without CPSP:
  • Patients fulfilling all of the following inclusion criteria are eligible for the study:
  • Informed Consent as documented by signature (Appendix Informed Consent Form)
  • History of thalamic stroke (infarction or bleed), at least 2 years ago
  • No chronic pain condition (neither CPSP or other pain condition)
  • Age ≥18 years old
  • Patients with migraine (other pain condition):
  • Patients fulfilling all of the following inclusion criteria are eligible for the study:
  • Informed Consent as documented by signature (Appendix Informed Consent Form)
  • History of highly frequent (≥8 monthly migraine days) or chronic migraine (≥15 monthly migraine days).
  • No history of stroke
  • Age ≥18 years old
  • Healthy controls:
  • Participants fulfilling all of the following inclusion criteria are eligible for the study:
  • Informed Consent as documented by signature (Appendix Informed Consent Form)
  • No history of stroke
  • No chronic pain condition
  • Age: ≥18 years old

排除标准

  • History of severe neurological, internistic or psychiatric disease
  • MRI related exclusion criteria:
  • paramagnetic and/or superparamagnetic foreign objects in the body (especially when located close to the brain)
  • Pacemaker
  • Claustrophobia
  • Pregnancy

结局指标

主要结局

The exact lesion location in the thalamus in patients with thalamic pain compared to patients with thalamic stroke without pain

时间窗: One time assessment with a duration of max. 90 minutes.

To determine the mutual lesion location in patients with CPSP of thalamic origin in standard stereotactic space using high-resolution 3 T MRI data and to calculate odds ratio maps for the risk of developing CPSP of thalamic origin with lesion of specific areas of the thalamus.

次要结局

  • Functional brain changes regarding the central processing of heat/cold stimulation in patients with thalamic pain compared to the other patient groups and the healthy controls(One time assessment with a duration of max. 90 minutes.)
  • Functional brain changes regarding the connectivity of pain networks in patients with thalamic pain compared to the other patient groups and the healthy controls(One time assessment with a duration of max. 90 minutes.)
  • Structural white matter changes in patients with thalamic pain compared to the other patient groups and the healthy controls(One time assessment with a duration of max. 90 minutes.)
  • Somatosensory profile of patients with thalamic pain vs. migraine (pain-control-group)(One time assessment with a duration of max. 60 minutes.)
  • Structural gray matter changes in patients with thalamic pain compared to the other patient groups and the healthy controls(One time assessment with a duration of max. 90 minutes.)

研究者

发起方
University Hospital, Basel, Switzerland
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验